Why Patients Are Switching to Wegovy Doses
Understanding Wegovy Doses for Treatment Switching
Switching between GLP-1 medications requires careful consideration of Wegovy doses and your current treatment regime. Unlike direct dose equivalents, Wegovy follows a specific escalation schedule: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and 2.4mg for maintenance from week 17 onwards. Patients switching from Mounjaro (tirzepatide) or Ozempic often restart this progression to minimise gastrointestinal side effects. Your prescriber will determine the most appropriate starting Wegovy dose based on your current medication, tolerance, and clinical response.
The switching process involves more than just dose conversion—it's about finding the right medication for your individual needs. Some patients switch due to side effect profiles, with Wegovy potentially offering different tolerability compared to dual-action Mounjaro. Others choose Wegovy for its longer room-temperature storage capability (6 weeks versus Mounjaro's 21 days), making it more convenient for travel. At EverydayMeds, we understand these nuances and stock both medications to support your transition without supply interruptions.
Wegovy Doses Pricing: Switch & Save Comparison
Our competitive Wegovy doses pricing makes switching financially sensible for many patients. Single pens start from £79.99 for the 0.25mg starter dose (with code FIRST40 for new customers or DOSE25 for returning customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. These prices represent significant savings compared to many high-street pharmacies, particularly when using our discount codes applied at checkout. For patients currently paying premium prices elsewhere, switching to EverydayMeds can reduce monthly medication costs substantially.
Our bundle options further enhance value whilst ensuring supply continuity during your switch. The Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks of treatment in a single order. For patients already on maintenance dosing, our Ultimate Stability Trio provides three 2.4mg pens for £649.99, ensuring uninterrupted treatment. These bundles eliminate the stress of timing multiple orders whilst providing peace of mind about supply availability—crucial when switching between medications.
Clinical Evidence Supporting Wegovy Doses
The STEP clinical trial programme demonstrates Wegovy's efficacy across its dose range, with the 2.4mg maintenance dose showing the most significant results. In STEP 1, patients taking Wegovy doses alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 2 trial specifically evaluated patients with type 2 diabetes, showing around 9.6% weight reduction, making it relevant for patients switching from diabetes medications like Ozempic.
The recent SELECT cardiovascular outcomes trial adds another dimension to Wegovy's clinical profile, demonstrating a 20% reduction in major cardiovascular events (HR 0.80) in patients with pre-existing cardiovascular disease. This evidence may influence switching decisions for patients with multiple comorbidities, though individual clinical assessment remains essential for determining the most appropriate treatment choice.
How Wegovy Doses Work in Your Body
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking a natural hormone that regulates appetite and food intake. When administered weekly, Wegovy doses activate receptors in the brain's appetite control centres, promoting feelings of fullness after smaller meals and potentially reducing food cravings. This mechanism differs from Mounjaro's dual GLP-1/GIP action, which may explain why some patients experience different side effect profiles or efficacy when switching. The gradual dose escalation schedule allows your body to adapt to increasing semaglutide levels whilst minimising gastrointestinal side effects commonly associated with GLP-1 medications. This prescription-only medicine works most effectively alongside a reduced-calorie diet and increased physical activity.
Ordering Your Wegovy Doses Through EverydayMeds
Switching to Wegovy doses through our platform takes just minutes to initiate. Our streamlined 3-minute online clinical assessment captures your medical history, current medications, and treatment goals, providing our prescribers with essential information for safe switching guidance. Following assessment submission, our clinical team reviews your case within 3 working days (or 24 hours with express service), ensuring appropriate dose selection and safety screening. Once approved, your Wegovy doses are dispatched via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for this prescription-only medicine. Our GPhC-registered pharmacy (#9012878) operates to the highest standards, providing the same professional service you'd expect from traditional pharmacies with added convenience.
Storing and Using Your Wegovy Doses Correctly
Proper storage of Wegovy doses ensures medication effectiveness and extends usability, particularly important when switching treatments. Unopened pens must be refrigerated at 2-8°C until first use, after which they can remain at room temperature below 30°C for up to 6 weeks—longer than Mounjaro's 21-day limit. Each FlexTouch pen contains four doses, administered once weekly via subcutaneous injection in your abdomen, thigh, or upper arm. The dose escalation cannot be skipped or rushed; each Wegovy dose level must be maintained for the prescribed duration to minimise side effects and optimise tolerance. This structured approach is particularly important when switching from other GLP-1 medications, as your body adapts to semaglutide's specific pharmacological profile.
Seamless Wegovy Doses Transition Management
EverydayMeds simplifies switching to Wegovy doses by stocking both your current and new medications, eliminating supply chain concerns during transition. Our clinical team can coordinate timing between your last Mounjaro or Ozempic dose and your first Wegovy injection, ensuring appropriate washout periods where necessary. Unlike single-medication pharmacies, our comprehensive GLP-1 portfolio means you're not forced to change suppliers when switching treatments, maintaining continuity of care and familiar ordering processes.
We also provide ongoing support throughout your Wegovy dose escalation journey, with reminder systems for dose progression and reordering alerts to prevent treatment gaps. This continuity proves invaluable for patients who've experienced supply issues elsewhere or faced complex switching procedures at traditional pharmacies. Our approach treats medication switching as a supported transition rather than a disruptive change.
Start Your Wegovy Doses Journey Today
Ready to switch and save with Wegovy doses? Our streamlined ordering process begins immediately at our weight management collection, where you can compare all available doses and bundles. New customers benefit from code FIRST40, while returning customers use DOSE25—both applied at checkout to reach our competitive pricing. Remember, these Wegovy doses require clinical assessment and prescriber approval, ensuring your safety whilst providing the convenience of online ordering. Don't let cost or convenience barriers prevent you from accessing the weight management support you need. Our expert clinical team, operating under GPhC registration #9012878, combines pharmaceutical expertise with practical affordability for your long-term treatment success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
